GRI Bio Inc.

NASDAQ: GRI · Real-Time Price · USD
1.40
-0.04 (-2.78%)
At close: Aug 15, 2025, 3:59 PM
1.44
2.86%
After-hours: Aug 15, 2025, 07:46 PM EDT

GRI Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a
Operating Income
-8.23M -11.39M -2.24M -1.06M
Interest Income
25K n/a n/a n/a
Pretax Income
-8.21M -13.04M -3.22M -1.56M
Net Income
-8.21M -13.04M -3.22M -1.56M
Selling & General & Admin
4.47M 8.15M 2M 813K
Research & Development
3.77M 3.23M 242K 249K
Other Expenses
n/a n/a n/a n/a
Operating Expenses
8.23M 11.39M 2.24M 1.06M
Interest Expense
n/a 2.08M 653K 547K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
8.23M 11.39M 2.24M 1.06M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
183.28K 44.18K 32.49K 324.87K
Shares Outstanding (Diluted)
183.28K 44.18K 32.49K 324.87K
EPS (Basic)
-55.21 -6.24K -165.35K -815.8
EPS (Diluted)
-55.21 -6.24K -165.35K -815.8
EBITDA
-8.23M -10.9M -2.51M -963K
EBIT
-8.23M -10.96M -2.56M -1.01M
Depreciation & Amortization
4K 57K 50K 73K